122 related articles for article (PubMed ID: 11348467)
1. The role of CTLA-4 in murine contact hypersensitivity.
Nuriya S; Enomoto S; Azuma M
J Invest Dermatol; 2001 May; 116(5):764-8. PubMed ID: 11348467
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand.
Tang A; Judge TA; Nickoloff BJ; Turka LA
J Immunol; 1996 Jul; 157(1):117-25. PubMed ID: 8683104
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice.
Hellings PW; Vandenberghe P; Kasran A; Coorevits L; Overbergh L; Mathieu C; Ceuppens JL
Eur J Immunol; 2002 Feb; 32(2):585-94. PubMed ID: 11828376
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
5. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
[TBL] [Abstract][Full Text] [Related]
6. Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease.
Vandenborre K; Delabie J; Boogaerts MA; De Vos R; Lorré K; De Wolf-Peeters C; Vandenberghe P
Am J Pathol; 1998 Apr; 152(4):963-73. PubMed ID: 9546357
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 can function as a negative regulator of T cell activation.
Walunas TL; Lenschow DJ; Bakker CY; Linsley PS; Freeman GJ; Green JM; Thompson CB; Bluestone JA
Immunity; 1994 Aug; 1(5):405-13. PubMed ID: 7882171
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
Krummel MF; Allison JP
J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
[TBL] [Abstract][Full Text] [Related]
9. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand.
Prud'homme GJ; Chang Y; Li X
Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas TL; Bakker CY; Bluestone JA
J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of anti-CTLA-4 antibody downregulates T cell function in vitro and in vivo.
Rao S; Vasu C; Martinez O; Kaithamana S; Prabhakar BS; Holterman MJ
Clin Immunol; 2001 Nov; 101(2):136-45. PubMed ID: 11683572
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
[TBL] [Abstract][Full Text] [Related]
13. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
[TBL] [Abstract][Full Text] [Related]
14. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes.
Ma J; Wang JH; Guo YJ; Sy MS; Bigby M
Cell Immunol; 1994 Oct; 158(2):389-99. PubMed ID: 7923390
[TBL] [Abstract][Full Text] [Related]
15. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies.
Ray MC; Tharp MD; Sullivan TJ; Tigelaar RE
J Immunol; 1983 Sep; 131(3):1096-102. PubMed ID: 6193174
[TBL] [Abstract][Full Text] [Related]
16. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
17. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.
Schwarz A; Beissert S; Grosse-Heitmeyer K; Gunzer M; Bluestone JA; Grabbe S; Schwarz T
J Immunol; 2000 Aug; 165(4):1824-31. PubMed ID: 10925260
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of CTLA-4 in Th1 and Th2 cells.
Alegre ML; Shiels H; Thompson CB; Gajewski TF
J Immunol; 1998 Oct; 161(7):3347-56. PubMed ID: 9759851
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
20. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
